Full-Time

Auditor – Medical Devices

Posted on 4/24/2026

Intertek

Intertek

10,001+ employees

Global testing, inspection, and certification provider

No salary listed

Remote in USA

Remote

Must reside in the United States; travel up to 3–5 nights per week to client sites.

Category
QA & Testing (1)
Requirements
  • A four year college or university degree in a science or technical field such as biology or microbiology; chemistry or biochemistry; computer and software technology; electrical, electronic, mechanical or bioengineering; human physiology; medicine; pharmacy; physics or biophysics, or an equivalent combination of relevant education and work experience.
  • A minimum of four or more years of full-time work experience in third party auditing with Lead Auditor qualification in Medical Device Single Audit Program and ISO 13485:2016 with an up to date audit log.
  • A minimum of four or more years of full-time work experience in a medical device or related medical device industry including design, development, testing, quality assurance or quality control.
  • A minimum of two or more years in a quality management systems environment including auditing, corrective and preventive action, complaints handling, and management review.
  • Strong communication and interpersonal skills.
  • Sound judgment, organizational and analytical skills.
  • Excellent computer and writing skills.
  • Ability to define problems, collect data, establish facts, and draw valid conclusions.
  • Ability to manage time effectively to complete assignments.
  • Willingness and ability to travel extensively, primarily domestically with some international travel (USA, Canada, Mexico).
  • Possess a valid unrestricted driver’s license and the ability to operate a motor vehicle during the performance of duties.
Responsibilities
  • Audit client management systems for compliance with established standards, client and industry requirements, government regulations, and other relevant standards, specifically ISO 13485, regulatory requirements for the United States, Canada, Japan, Australia, and Brazil, and GMP regulatory requirements related to the medical device, pharmaceutical and cosmetic industry.
  • Assist clients with questions relevant to the audit and/or certification process.
  • Act as Lead Auditor or as a team member.
  • Travel will include overnight stays of 3 to 5 days per week at various worksites and client locations.
  • Coordinate audit activity with team members.
  • Liaise with clients regarding audit activity.
  • Review client’s quality management system documentation.
  • Verify and document evidence of compliance and non-compliance.
  • Prepare audit reports.
  • Review audit results with the coordinator and other assessment team members and make presentations to clients and/or certification board concerning audit results when required.
  • Assist with corrective action requirements resulting from assessments.
  • Participate in audit meetings.
  • Review audit reports and provide technical assistance to the medical team.
  • Support management in areas of continuous improvement.
  • Provide management with updates on status of work, initiatives, and projects as required.
Desired Qualifications
  • Lead Auditor Training with ISO 19011 or ISO 13485 certification.
  • MDR Notified Body auditing experience.
  • Related third party auditing industry management systems experience with a third party audit log with at least six audits totaling a minimum of fifteen audit-days in a 12-month period, with at least two of these audits being initial or recertification audits and the Lead Auditor role in at least two of these six audits within the last 12 months.
  • Working knowledge of regulatory requirements for medical devices and pharmaceuticals in the European Union, United States, Australia, Japan, Brazil, and/or Canada.
  • Experience implementing or auditing to ISO 13485, ISO 14971, and medical device regulatory requirements.
  • Device industry experience with orthopedic implants, active devices, software as a medical device, monitoring devices, in vitro fertilization and assisted reproductive technology devices, and sterility requirements such as ethylene oxide or gamma sterilization.
  • Specific experience or training on manufacturing processes used in the relevant industry, such as sterilization, machinery, electrical and electronic devices or components, or software development.
  • Training or experience in quality tools such as Kaizen or lean manufacturing.

Intertek provides assurance, inspection, product testing, and certification services to a wide range of industries around the world. It helps clients assess their products and commodities to ensure they meet quality, safety, and performance standards. With a global network of laboratories and facilities, Intertek offers Total Quality Assurance (TQA) across the entire product lifecycle—from research and development to manufacturing and distribution. Revenue comes from fees for testing, inspection, and certification. What sets Intertek apart is its broad, end-to-end service offering and extensive geographic reach, enabling comprehensive risk management, quality control, and supply-chain solutions across many sectors. Its goal is to help customers improve product quality and safety while mitigating risks across their operations and supply chains.

Company Size

10,001+

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1885

Simplify Jobs

Simplify's Take

What believers are saying

  • Consumer Products division grew 6.2% revenue with 250bp margin expansion to 30.4% in 2025.
  • Q1 2026 like-for-like revenue rose 5.4% to £838.5M, guiding mid-single-digit growth.
  • QTEST acquisition expands ETL capabilities in high-growth Latin American markets.

What critics are saying

  • EQT's $12.2B hostile bid forces sale or distracts management from operations now.
  • World of Energy revenue fell 1.3% in 2025 from reduced client investments.
  • CFO Colm Deasy departs April 10, 2026, disrupting strategy amid takeover pressure.

What makes Intertek unique

  • Intertek leads as world's largest consumer goods tester with 1,000+ labs in 100 countries.
  • Provides Total Quality Assurance via ATIC services across 25 industries globally.
  • Holds 3.7% US market share in laboratory testing services as incumbent leader.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Intertek who can refer or advise you

Benefits

Health Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Professional Development Budget

Wellness Program

Company News

Yahoo Finance
Apr 14th, 2026
Intertek reviews split into two businesses, reports 5.4% Q1 revenue growth to $1.1B

Intertek Group has launched a strategic review to assess splitting into two specialist businesses — Intertek Testing & Assurance and Intertek Energy & Infrastructure — with any separation targeted for completion by mid-2027. Options under consideration include demerger, sale or alternative listings, though no final decision has been made. The announcement accompanied a strong first quarter, with like-for-like revenue growth of 5.4% and reported revenue of £838.5 million. Growth was driven by volume and pricing across divisions, with continued margin progression and strong free cash flow. CEO André Lacroix said the review reflects management's view that the company's generalist portfolio model "might be reaching its potential". The company reaffirmed full-year guidance of mid-single-digit like-for-like growth and plans capital expenditure of £150–160 million.

Yahoo Finance
Apr 6th, 2026
Intertek analysts cut fair value target to $66.88 as price views diverge from $56.83 to $72.61

Analysts have trimmed Intertek Group's fair value estimate slightly, with the central price target moving from £53.46 to £52.66 per share. Individual targets range from £44.75 to £57.17, reflecting mixed sentiment across Buy, Neutral and Sector Perform ratings. Citi maintains a Buy rating with targets of £58.47 and £57.17, expressing confidence in Intertek's execution capabilities. However, RBC Capital cut its target to £44.75 with a Sector Perform rating, whilst JPMorgan's Neutral stance suggests limited near-term upside without fresh catalysts. The company announced Laura Crespi will replace Colm Deasy as Group CFO in April 2026, and has launched an expanded Digital Product Passport suite for sustainability compliance. The board proposes a final dividend of 107.7p per share.

London School of Economics and Political Science
Mar 26th, 2026
Intertek promotes Laura Crespi to CFO as Colm Deasy moves to Vietnam.

Intertek promotes Laura Crespi to CFO as Colm Deasy moves to Vietnam. Thu, 26th Mar 2026 09:36 (Alliance News) - Intertek Group PLC on Thursday said Colm Deasy will step down from the board and as chief financial officer to move to an operational role in Asia Pacific, promoting internally to replace him. The London-based assurance, inspection, product testing and certification company said Deasy will become executive vice president for Asia Pacific, based in Vietnam, from April 10, and will cease to be an executive director and CFO on the same date. Intertek said it promoted Laura Crespi to group CFO from April 10. Crespi, currently regional CFO for Europe, Middle East and Africa, will join the board as an executive director and become a member of the group executive committee. Intertek Chief Executive Officer Andre Lacroix said: "I am delighted with these two organisational changes. Colm has been with the group for over 9 years and in that time has been an excellent contributor in both operational and finance roles with a strong track record of delivering quality growth on a consistent basis for all our stakeholders." Crespi joined Intertek in 2023, prior to which she was CFO for Global Nexis Solutions at business and professional information provider Relx PLC. Intertek shares were 0.8% lower at 3,692.00 pence each on Thursday morning in London. By Tom Budszus, Alliance News slot editor

Yahoo Finance
Mar 13th, 2026
Intertek launches Digital Product Passport services for circular economy compliance

Intertek has launched a comprehensive Digital Product Passport suite of services to help manufacturers, brands and retailers navigate regulatory requirements and sustainability reporting. The services support compliance with the EU's Ecodesign for Sustainable Products Regulation, Battery Regulation and other sector-specific legislation. The offering includes advisory services for transparency, traceability and circular economy principles across product lifecycles. Intertek's solutions enable organisations to manage sustainability and compliance data through auditable processes whilst demonstrating verifiable performance to regulators and stakeholders. The launch responds to mounting pressure on companies to implement robust systems for sustainability reporting. Organisations can contact Intertek for readiness assessments or to discuss circular economy strategies as regulatory frameworks for product sustainability performance continue to evolve globally.

Public Sector Catering
Mar 13th, 2026
Travel caterer SSP appoints Andrew Martin as new chair of board

Travel caterer SSP appoints Andrew Martin as new chair of board. 13th Mar 2026 - 05:00 SSP Group, an operator of restaurants, bars, cafes and other food and beverage outlets in travel locations across 38 countries, has appointed Andrew Martin as chair of the board with effect from 1st June 2026. Martin succeeds Carolyn Bradley, who has served as interim chair since the AGM on 23rd January 2026. She will remain on the board as senior independent director. He has extensive experience across the global consumer, travel, hospitality and support services sectors. Martin is currently chair of Intertek Group plc, a FTSE 100 company, and is stepping down at the end of May 2026 after more than five years in his current role and ten years in total as a non-executive director. Previously Martin held board-level executive roles at Compass Group plc from 2004 to 2015, including group chief operating officer for Europe and Japan as well as group finance director. Commenting on his new role, Martin said: "The company operates in an attractive industry and has a strong business model with clear opportunities for value creation. I look forward to working with the board, Patrick and the broader leadership team to drive strong execution of the 'Focus26' agenda and to help shape strategy to deliver strengthened value for shareholders and other stakeholders."

INACTIVE